Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia
- PMID: 38470864
- PMCID: PMC11651691
- DOI: 10.1210/clinem/dgae158
Lower Prevalence of Diabetic Ketoacidosis at Diagnosis in Research Participants Monitored for Hyperglycemia
Abstract
Context: In Colorado children, the prevalence of diabetic ketoacidosis (DKA) at diagnosis of type 1 diabetes has been increasing over time.
Objective: To evaluate the prevalence of and factors involved in DKA at type 1 diabetes diagnosis among participants followed in monitoring research studies before diagnosis compared to patients from the community.
Methods: We studied patients < 18 years diagnosed with type 1 diabetes between 2005 and 2021 at the Barbara Davis Center for Diabetes and compared the prevalence of and factors associated with DKA at diagnosis among participants in preclinical monitoring studies vs those diagnosed in the community.
Results: Of 5049 subjects, 164 were active study participants, 42 inactive study participants, and 4843 were community patients. Active study participants, compared to community patients, had lower HbA1c (7.3% vs 11.9%; P < .001) and less frequently experienced DKA (4.9% vs 48.5%; P < .001), including severe DKA (1.2% vs 16.2%; P < .001). Inactive study participants had intermediate levels for both prevalence and severity of DKA. DKA prevalence increased in community patients, from 44.0% to 55%, with less evidence for a temporal trend in study participants. DKA prevalence was highest in children < 2 years (13% in active study participants vs 83% in community patients). In community patients, younger age (P = .0038), public insurance (P < .0001), rural residence (P < .0076), higher HbA1c (P < .0001), and ethnicity minority status (P < .0001) were associated with DKA at diagnosis.
Conclusion: While DKA prevalence increases in community patients over time, it stayed < 5% in active research participants, who have a 10 times lower prevalence of DKA at diagnosis, including among minorities.
Keywords: diabetic ketoacidosis; monitoring; pediatric; screening; type 1 diabetes.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Figures
Similar articles
-
Diabetic Ketoacidosis at Diagnosis of Type 1 Diabetes in Colorado Children, 2010-2017.Diabetes Care. 2020 Jan;43(1):117-121. doi: 10.2337/dc19-0428. Epub 2019 Oct 10. Diabetes Care. 2020. PMID: 31601639 Free PMC article.
-
Diabetic ketoacidosis at diagnosis of type 1 diabetes and glycemic control over time: The SEARCH for diabetes in youth study.Pediatr Diabetes. 2019 Mar;20(2):172-179. doi: 10.1111/pedi.12809. Epub 2018 Dec 27. Pediatr Diabetes. 2019. PMID: 30556249 Free PMC article.
-
Diabetic Ketoacidosis Severity at Diagnosis and Glycaemic Control in the First Year of Childhood Onset Type 1 Diabetes-A Longitudinal Cohort Study.Int J Environ Res Public Health. 2017 Dec 25;15(1):26. doi: 10.3390/ijerph15010026. Int J Environ Res Public Health. 2017. PMID: 29295580 Free PMC article.
-
Prevalence and factors associated with diabetic ketoacidosis at diagnosis of type 1 diabetes: A report from a tertiary medical center in Central Pennsylvania.Endocrinol Diabetes Metab. 2020 Sep 12;4(2):e00186. doi: 10.1002/edm2.186. eCollection 2021 Apr. Endocrinol Diabetes Metab. 2020. PMID: 33855199 Free PMC article.
-
Factors Associated With Diabetic Ketoacidosis at Onset of Type 1 Diabetes Among Pediatric Patients: A Systematic Review.JAMA Pediatr. 2022 Dec 1;176(12):1248-1259. doi: 10.1001/jamapediatrics.2022.3586. JAMA Pediatr. 2022. PMID: 36215053
Cited by
-
Regional Deprivation and Diabetic Ketoacidosis at Type 1 Diabetes Diagnosis in Children and Adolescents: International Comparison among 6 Countries.Horm Res Paediatr. 2024 Dec 12:1-8. doi: 10.1159/000543139. Online ahead of print. Horm Res Paediatr. 2024. PMID: 39667350
-
Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type 1 Diabetes: A Brief Report.Diabetes Ther. 2024 Oct;15(10):2249-2261. doi: 10.1007/s13300-024-01637-z. Epub 2024 Aug 27. Diabetes Ther. 2024. PMID: 39190273 Free PMC article.
-
Unlocking the dual healing powers of plant-based metallic nanoparticles: managing diabetes and tackling male infertility challenges.Front Endocrinol (Lausanne). 2025 Jul 4;16:1482127. doi: 10.3389/fendo.2025.1482127. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40687580 Free PMC article. Review.
-
Health economic considerations of screening for early type 1 diabetes.Diabetes Obes Metab. 2025 Aug;27 Suppl 6(Suppl 6):69-77. doi: 10.1111/dom.16522. Epub 2025 Jun 24. Diabetes Obes Metab. 2025. PMID: 40555704 Free PMC article. Review.
References
-
- Ogle GD, Wang F, Gregory GA, Maniam J. Type 1 diabetes estimates in children and adults in IDS atlas reports. In: Magliano DJ, Boyko EJ, Genitsaridi I, Piemonte L, Riley P, Salpea P, eds. International Diabetes Foundation; 2022:4‐14.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical